Distinguishing Crohn's Disease from Ulcerative Colitis
Crohn's disease and ulcerative colitis are distinct inflammatory bowel diseases that differ fundamentally in anatomical distribution, depth of inflammation, and complications—differences that directly impact treatment decisions and prognosis. 1
Anatomical Distribution
Ulcerative colitis begins in the rectum and extends proximally in a continuous, uninterrupted pattern, affecting only the colon with gradually decreasing severity of inflammation moving proximally. 1, 2 Rectal involvement is present in over 97% of untreated UC cases. 3
Crohn's disease demonstrates patchy, discontinuous inflammation with skip lesions and can affect any part of the gastrointestinal tract from mouth to anus. 1, 2 The terminal ileum is the most commonly affected site. 1 Rectal sparing occurs commonly in CD but is rare in UC (only up to 3% of cases), making this a key distinguishing feature. 1, 3
Depth of Inflammation
The single most critical pathophysiologic difference is the depth of tissue involvement:
- Ulcerative colitis inflammation is limited to the mucosa and occasionally the submucosa only. 1, 2, 4
- Crohn's disease exhibits transmural inflammation extending through all layers of the intestinal wall (mucosa, submucosa, muscularis propria, and serosa). 1, 2, 4
This transmural nature in CD drives the development of stricturing and penetrating complications including fistulas, which are hallmark features of Crohn's disease. 1 Approximately one-quarter of perianal fistulas in CD present at or before diagnosis. 1
Histological Features
Granulomas are absent in UC but present in CD, serving as a key distinguishing microscopic feature. 1, 2 When present, non-caseating granulomas are pathognomonic for Crohn's disease. 1
Additional microscopic differences include:
- Crypt abscesses are more common in UC (41%) than in CD (19%). 2, 3
- Inflammatory pattern: UC shows diffuse inflammation without variations in intensity, while CD shows focal inflammation that varies in intensity within and between biopsies. 1, 2
- Mucin depletion is pronounced in UC but uncommon and mild in CD. 1, 2
- Fissures are characteristically absent in UC but present in CD. 2
Complications
Fistulas represent a hallmark complication of Crohn's disease due to transmural inflammation, allowing penetration through the bowel wall to adjacent structures or skin. 1 Perianal fistulas and ulcers are common in CD but rare in UC. 4
Strictures differ mechanistically: In UC, strictures result from mucosal/submucosal fibrosis only, whereas CD strictures involve all layers of the bowel wall. 1, 2
Colorectal cancer risk is increased in both conditions, but the risk appears equivalent in Crohn's colitis and UC when matched for extent and duration of colonic involvement. 1 However, cancer is historically more common in UC due to more extensive colonic involvement. 4
Diagnostic Approach
Perform complete ileocolonoscopy with at least two biopsies from five different sites (including ileum and rectum, even from normal-appearing areas) to differentiate CD from UC. 1, 3 This is imperative even if initial sigmoidoscopy suggests UC. 3
Systematically complete with cross-sectional imaging (MRI or CT enterography) to evaluate small intestine involvement, as about one-third of CD patients have small intestine disease not detectable by colonoscopy. 1, 3
Obtain basic laboratory assessment including complete blood count, CRP, albumin, liver function tests, iron status, renal function, and vitamin B12. 3
Fecal calprotectin has 93% sensitivity and 96% specificity for diagnosing IBD in adults, with an optimal threshold of 100 μg/g. 3
Common Pitfalls
In 5-15% of IBD cases, endoscopic and histological evaluation cannot distinguish between CD and UC (termed indeterminate colitis or IBD-unclassified). 2, 3, 5 In these cases, capsule endoscopy can establish a definitive CD diagnosis by demonstrating small intestine lesions in 17-70% of patients. 1, 3
Exclude infectious causes before finalizing diagnosis, as infections (particularly Clostridioides difficile and cytomegalovirus) can mimic IBD. 3, 5 Testing for C. difficile toxin is mandatory when an IBD flare is suspected. 3
Medical treatment can alter typical patterns: Therapy can modify the continuous inflammation pattern in UC, potentially inducing discontinuous inflammation reminiscent of CD. 5 In cases of diagnostic doubt, review original biopsies to ascertain the diagnosis. 5
Recognize that UC is not "cured" by colectomy: Postoperative complications, especially pouchitis and fecal incontinence, affect more than one-third of patients after surgery. 6 While total colectomy removes the diseased colon, it does not eliminate all disease burden. 6